Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: AlmeeTM

Vicore Pharma’s DTx to benefit pulmonary fibrosis patients

The nine-week DTxl CBT helps to address psychological symptom burdens in PF patients

January 8, 2024 Alex Therapeutics, AlmeeTM, COMPANION, idiopathic pulmonary fibrosis, News, pulmonary fibrosis, Vicore Pharma
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy